what if pain medicine advises narcotics despite a history of aberrant behavior and you don't want to prescribe them? as i said before, there is little incentive for pain management in the va to discourage narcotics if they are not doing the refills...
in addition, is there any way to "force" pain medicine to do the refills if there is a disagreement? thanks...
Take a look at these two alternative models. The first keeps pain management's skin in the game with a ménage à trois contract between the patient, the primary, and the specialist. If pain management is dumping opioids on the primary this should be mandatory. The second is a nurse opioid refill clinic - in a VA coincidentally - that is run like a coumadin clinic.
1. J Pain Symptom Manage. 2002 Sep;24(3):335-44.
The trilateral opioid contract. Bridging the pain clinic and the primary care physician through the opioid contract.
Fishman SM, Mahajan G, Jung SW, Wilsey BL.
Source
Department of Anesthesiology and Pain Medicine, University of California, Davis, USA.
Abstract
We have extended the traditional use of opioid contracts to involve the primary care physician (PCP). The PCP was asked to collaborate with the pain specialist's decision to use opioids by cosigning an opioid contract. Explicit in the agreement was the understanding that the primary care physician would assume prescribing the refills for these medications once the opioid regimen had become stabilized. The present study was a retrospective chart review of the first 81 patients with non-malignant chronic pain who received an opioid agreement requiring the participation of the primary care physician. Sixty-nine of the 81 patients (85%) agreed to the terms of the contract initially, but only 50 of these 69 individuals (72%) successfully obtained their PCP's written agreement for the prescribing of opioids for chronic pain management. Despite expecting reluctance on the part of the PCP to enter into this agreement, the low compliance rate was due to lack of commitment on the part of the patient, who either refused to sign the contract outright or, after initially agreeing to sign the contract, did not have it signed by the PCP. If the PCP did not agree to sign the opioid contract, the patient was tapered off the medication. If the contract was approved and signed by the PCP, there were no subsequent reversals by this physician in terms of agreeing to continue to prescribe opioids. In all cases in which a contract was completed, the patient was successfully stabilized on an appropriate opioid regimen and then discharged back to the care of the PCP for long-term opioid treatment. The opioid contract may be an effective tool for networking specialty and primary care services in the delivery of chronic opioid therapy.
Comment in
J Pain Symptom Manage. 2003 May;25(5):402-3; author replay 403-4.
2. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse.
Wiedemer NL, Harden PS, Arndt IO, Gallagher RM.
Source
Philadelphia VA Medical Center, Philadelphia, Pennsylvania 19104, USA.
[email protected]
Abstract
OBJECTIVE:
To measure the impact of a structured opioid renewal program for chronic pain run by a nurse practitioner (NP) and clinical pharmacist in a primary care setting.
PATIENTS AND SETTING:
Patients with chronic noncancer pain managed with opioid therapy in a primary care clinic staffed by 19 providers serving 50,000 patients at an urban academic Veterans hospital.
DESIGN:
Naturalistic prospective outcome study.
INTERVENTION:
Based on published opioid prescribing guidelines and focus groups with primary care providers (PCPs), a structured program, the Opioid Renewal Clinic (ORC), was designed to support PCPs managing patients with chronic noncancer pain requiring opioids. After training in the use of opioid treatment agreements (OTAs) and random urine drug testing (UDT), PCPs worked with a pharmacist-run prescription management clinic supported by an onsite pain NP who was backed by a multi-specialty Pain Team. After 2 years, the program was evaluated for its impact on PCP practice and satisfaction, patient adherence, and pharmacy cost.
RESULTS:
A total of 335 patients were referred to the ORC. Of the 171 (51%) with documented aberrant behaviors, 77 (45%) adhered to the OTA and resolved their aberrant behaviors, 65 (38%) self-discharged, 22 (13%) were referred for addiction treatment, and seven (4%) with consistently negative UDT were weaned from opioids. The 164 (49%) who were referred for complexity including history of substance abuse or need for opioid rotation or titration, with no documented aberrant drug-related behaviors, continued to adhere to the OTA. Use of UDT and OTAs by PCPs increased. Significant pharmacy cost savings were demonstrated.
CONCLUSION:
An NP/clinical pharmacist-run clinic, supported by a multi-specialty team, can successfully support a primary care practice in managing opioids in complex chronic pain patients.